Get started
Author

Guido Ahle

Observed names: Ahle, G., G Ahle, G. Ahle
ORCID: 0000-0002-0877-2289
Observed ORCID: 0000-0002-0877-2289
OpenAlex ID: A5110894864
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis
2020 · Céline Louapre, Nicolas Collongues, et al. · JAMA Neurology · 455
PDF
Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data
2018 · Bruce C V Campbell, Charles B L M Majoie, et al. · The Lancet Neurology · 406
PDF
Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data
2018 · Luis San Román, Bijoy K Menon, et al. · The Lancet Neurology · 391
PDF
Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data
2017 · Bruce C V Campbell, Wim H van Zwam, et al. · The Lancet Neurology · 295
PDF
Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis
2020 · Céline Louapre, Nicolas Collongues, et al. · Multiple Sclerosis Journal · 103
Diagnosis of multiple sclerosis: comparison of the Poser criteria and the new McDonald criteria
2003 · T. Fangerau, S. Schimrigk, et al. · Acta Neurologica Scandinavica · 59
Development and Validation of a Postprocedural Model to Predict Outcome After Endovascular Treatment for Ischemic Stroke
2023 · Vicky Chalos, Esmee Venema, et al. · JAMA Neurology · 51
PDF
High risk of recurrence for grade II meningioma: a 10-year multicenter analysis of prognosis factors
2021 · Laura Bender, François Somme, et al. · Chinese Clinical Oncology · 24
PDF
Klinische Charakteristika von Patienten mit tardiven Dyskinesien
2000 · T Held, T Weber, et al. · Fortschritte der Neurologie · Psychiatrie · 7
Bispecific antibody therapy in multiple myeloma and risk of progressive multifocal leukoencephalopathy
2026 · Jean-Roch Le Henaff, Loïc Le Guennec, et al. · Blood Advances · 3
Diagnostic Value of the Kappa Free Light Chain Index to Distinguish MOGAD, NMOSD, and MS
2026 · Apolline Tournier, Antoine Gavoille, et al. · Neurology · 3
Chasing the dragon: Case report of positive recovery from cocaine inhaled induced leukoencephalopathy
2017 · Marion Mc Cavana, Guido Ahle, et al. · Annals of Physical and Rehabilitation Medicine · 1
PDF
Neue Entwicklungen in der Gliomtherapie
2010 · A. Kowoll, G. Ahle, et al. · Aktuelle Neurologie · 1
Reference frame for Adult Brainstem gliomas
2026 · Florence Laigle-Donadey, Emmanuel Mesny, et al. · The Oncologist
PDF
P11.09.B Chemotherapy is an efficient treatment in primary CNS MALT lymphoma
2022 · C Desjardins, D Larrieu-Ciron, et al. · Neuro-Oncology
PDF
Prospective Evaluation of Alternative Therapies in Glioma Patients in France
2018 · Le Rhun, E., Frenay, C. Lebrun, et al. · HAL
Frühe Balkenatrophie bei MS: Vergleich Spontanverlauf – Immunprophylaxe
2009 · H Shanib, M Arp, et al. · Aktuelle Neurologie
Zentrale Hirnatrophie im Corpus callosum bei schubförmiger Multipler Sklerose: früh und ausgeprägt
2007 · H Shanib, M Arp, et al. · Aktuelle Neurologie
Mitoxantron bei Multipler Sklerose – Abbruchgründe und Folgetherapien
2006 · S. Maug, M. Kaeder, et al. · Aktuelle Neurologie
Works count: 21
Citation count: 1,799
H-index: 8
I10-index: 8
Year
Topic
Type